VIANEER Trademark

Trademark Overview

On Monday, November 29, 2010, a trademark application was filed for VIANEER with the United States Patent and Trademark Office. The USPTO has given the VIANEER trademark a serial number of 85185847. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 26, 2014. This trademark is owned by JOHNSON & JOHNSON. The VIANEER trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceuticals for the treatment of ophthalmic diseases, muscle dystonias, wrinkles and smooth muscle disorders, gastro-intestinal diseases
vianeer

General Information

Serial Number85185847
Word MarkVIANEER
Filing DateMonday, November 29, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 26, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 22, 2011

Trademark Statements

Goods and ServicesHuman pharmaceuticals for the treatment of ophthalmic diseases, muscle dystonias, wrinkles and smooth muscle disorders, gastro-intestinal diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 2, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001

Trademark Events

Event DateEvent Description
Tuesday, May 27, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 26, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, October 11, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 10, 2013EXTENSION 5 GRANTED
Thursday, October 3, 2013EXTENSION 5 FILED
Thursday, October 3, 2013TEAS EXTENSION RECEIVED
Wednesday, March 27, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 26, 2013EXTENSION 4 GRANTED
Wednesday, March 20, 2013EXTENSION 4 FILED
Wednesday, March 20, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 5, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 4, 2012EXTENSION 3 GRANTED
Tuesday, October 2, 2012EXTENSION 3 FILED
Tuesday, October 2, 2012TEAS EXTENSION RECEIVED
Thursday, May 3, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 2, 2012EXTENSION 2 GRANTED
Tuesday, April 3, 2012EXTENSION 2 FILED
Wednesday, May 2, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 3, 2012TEAS EXTENSION RECEIVED
Tuesday, April 3, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 19, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, October 17, 2011EXTENSION 1 GRANTED
Monday, October 17, 2011EXTENSION 1 FILED
Monday, October 17, 2011TEAS EXTENSION RECEIVED
Tuesday, April 19, 2011NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 22, 2011PUBLISHED FOR OPPOSITION
Wednesday, February 2, 2011NOTICE OF PUBLICATION
Saturday, January 15, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 14, 2011ASSIGNED TO LIE
Thursday, December 23, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 16, 2010ASSIGNED TO EXAMINER
Thursday, December 2, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 2, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

vianeer diseases muscle smooth disorders gastro intestinal wrinkles dystonias ophthalmic pharmaceuticals